RaySearch Laboratories: Interim report January 1 - March 31, 2024
STOCKHOLM, May 17, 2024 /PRNewswire/ --
FIRST QUARTER (JANUARY - MARCH 2024)
Oder intake SEK 238.5 M (206.6)
Net sales SEK 257.2 M (230.2)
Operating profit SEK 45.8 M (23.7)
Profit after tax SEK 36.7 M (17.6)
Earnings per share before/after dilution SEK 1.07 (0.51)
Cash flow SEK 87.9 M (84.5)
Order backlog SEK 1,848.0 M (1,903.3) MSEK at the end of the period
SIGNIFICANT EVENTS DURING THE FIRTS QUARTER
RayStation in more than 1,000 radiotherapy centers worldwide.
The Royal Marsden set to be the first center in the world to implement online adaptive radiation therapy utilizing ARTemis from RaySearch.
RaySearch acquires the product DrugLog from Pharmacolog.
World leading carbon ion center QST in Chiba, Japan, selects RayStation.
SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD
Raigmore Hospital in Scotland selects RayCare.
RaySearch and C-RAD signed collaboration agreement.
RayCare has been certified to be interoperable with Varian TrueBeam.
WEBCAST
CEO Johan Löf and Interim CFO Annika Blondeau Henriksson will present RaySearch's interim report for January-March 2024 at a webcast to be held in English on Friday, May 17, 2024 at 10:00 a.m. CET.
You can also join the webcast by phone: Sverige: +46 (0) 8 505 100 31 UK: +44 (0) 207 107 06 13 US: +1 (1) 631 570 56 13
The information contained in this interim report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication on May 17, 2024 at. 7:45 a.m. CET.
For more information, please contact: Johan Löf, founder and CEO, RaySearch Laboratories AB (publ) Telephone: +46 (0) 8 510 530 00 [email protected]
Mindbloom, the leading provider of psychedelic therapy, announced today the findings of the largest peer-reviewed study in the history of ketamine therapy and psychedelic medicine. The study was published in the Journal of Affective Disorders, and...
Projected to grow at a CAGR of 10.5%, the global medical equipment maintenance market is anticipated to reach USD 88.9 billion by 2029, up from USD 54.0 billion in 2024. This growth is fueled by the escalating prevalence of chronic diseases such as...
MDpanel, a provider of expert medical opinions as part of the insurance claims process, has expanded its presence in the Midwest with the addition of Medical Evaluators, an Ohio-based provider of independent medical evaluations (IMEs), to its...
The projected global single-use bioprocessing market is expected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, with a CAGR of 14.5%. Key players such as Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, Inc., and Merck...
The Canadian Medical Association (CMA) is disappointed and frustrated with the federal tax proposal tabled on June 11 that offered no consideration for physicians who rely on their professional corporations to provide much-needed health care...